Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Ceftolozane/Tazobactam in Adult CF Patients
NCT02421120Phase 4Completed
- Sponsor
- Joseph L. Kuti
- Start
- Sep 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftolozane + tazobactam in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Joseph L. Kuti. Started Sep 2015; status: completed.
02
Drugs
ceftolozane + tazobactam
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT02421120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421120.